Trademark: 97787004
Word
C CELLPOINT
Status
Pending
Status Code
681
Status Date
Friday, May 17, 2024
Serial Number
97787004
Mark Type
3
Filing Date
Wednesday, February 8, 2023
Published for Opposition
Tuesday, June 25, 2024

Trademark Owner History

Classifications
41 Education services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals
5 Pharmaceutical substances and preparations for human use, namely, pharmaceutical preparations and engineered patient T cells for the treatment of cancer; biopharmaceutical substances and preparations for human use, namely, biopharmaceutical preparations and engineered patient T cells for the treatment of cancer; clinical diagnostic reagents for medical use
44 Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others being engineered patient T-cells; medical services, namely, Stemcell and celltherapy services; Medical services relating to the removal, treatment and processing of human cells
42 Medical, scientific and industrial research services in the field of pharmaceuticals, engineered patient T-cells, cell therapy, and gene therapy; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expression, namely, analysis and testing of cells to determine the presence of particular genes; analysis and testing of cells to determine efficacy for treatment of cancer; development, examination, namely, quality control, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis and testing of medicaments; development of test systems in the nature of testing procedures and protocols, computer software for testing, reagents and testing kits for testing for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of computer databanks containing information concerning gene expression and gene therapy; pharmaceutical drug development services; scientific research in the nature of conducting clinical trials for others; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of a red dot to the left of the letter "C" outlined in a blue and green background, to the left of the word "CELLPOINT" in stylized blue font.
C CELL POINT
The color(s) blue, red, and green is/are claimed as a feature of the mark.

Trademark Events
Feb 11, 2023
New Application Entered
Feb 28, 2023
New Application Office Supplied Data Entered
Mar 1, 2023
Notice Of Design Search Code E-Mailed
Aug 21, 2023
Assigned To Examiner
Aug 25, 2023
Non-Final Action Written
Aug 25, 2023
Non-Final Action E-Mailed
Aug 25, 2023
Notification Of Non-Final Action E-Mailed
Sep 17, 2023
Teas Response To Office Action Received
Nov 6, 2023
Assigned To Examiner
Feb 7, 2024
Assigned To Lie
Feb 7, 2024
Correspondence Received In Law Office
Feb 7, 2024
Teas/Email Correspondence Entered
Feb 9, 2024
Approved For Pub - Principal Register
Feb 16, 2024
On Hold - Electronic Record Review Required
Jun 5, 2024
Notification Of Notice Of Publication E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24